Recent progress in discovery of novel AAK1 inhibitors: from pain therapy to potential anti-viral agents

Author:

Yuan Ying-Hui12,Mao Nian-Dong12,Duan Ji-Long12,Zhang Hang23,Garrido Carmen456,Lirussi Frédéric47,Gao Yuan128,Xie Tian12,Ye Xiang-Yang12

Affiliation:

1. School of Pharmacy, Hangzhou Normal University, Hangzhou, Zhejiang, China

2. Key Laboratory of Elemene Class Anti-Cancer Chinese Medicines; Engineering Laboratory of Development and Application of Traditional Chinese Medicines; Collaborative Innovation Center of Traditional Chinese Medicines of Zhejiang Province, Hangzhou Normal University, Hangzhou, Zhejiang, China

3. School of Basic Medical Science, Hangzhou Normal University, Hangzhou, China

4. INSERM UMR 1231, Labex LipSTIC, University of Bourgogne, Dijon, France

5. Cancer Center George François Leclerc, Dijon, France

6. University of Bourgogne Franche-Comté, Besançon, France

7. University of Franche-Comté & University Hospital of Besançon, Besancon, France

8. Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Shanghai, China

Funder

National Natural Science Foundation of China

Science and Technology Department of Zhejiang Province

the Medical Health Science and Technology Project of Zhejiang Provincial Health Commission

the Ministry of Science and Technology of China

Hangzhou’s “115” plan to introduce overseas intelligence projects

Hangzhou Normal University startup fund

la Ligue Nationale contre le Cancer

Ruban Rose Foundation

FEDER

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmacology,General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3